Neurology (46%)

We have been working in the field of cell therapy since 2013 since the law on the use of mesenchymal stem cells in medicine came into force.

​

The statistical data can be seen in the table chart:

Aesthetic medicine (3%) includes scars and age-related skin changes

​

Urology (1%): urinary incontinence due to stress in women, restoration of erectile function in men

 

Traumatology (5%): arthritis, osteoarthritis of the knee, hip, shoulder and other joints; aseptic necrosis of the femoral head; false joints and bone fractures not consolidated for a long time, post-traumatic osteomyelitis of long tubular bones with bone defects.

 

Neurology (46%): multiple sclerosis, infantile cerebral palsy, autism, epilepsy, amyotrophic lateral sclerosis (ALS), paraplegia, tetraplegia, hemiparesis, tetraparesis, post-stroke conditions.

 

Rheumatology (14%): fibromyalgia, systemic lupus erythematosus, systemic scleroderma, Raynaud's syndrome, osteoporosis.

 

Pulmonology (11%): idiopathic fibrosing alveolitis (ELISA) and chronic obstructive pulmonary disease (COPD), recovery after covid.

 

Phthistiology (6%): lung tuberculosis with extensive and complete drug resistance.

 

Cardiology (2%): ischemic heart disease, post-infarction myocardyopathy.

 

Therapy (5%): treatment of chronic hepatitis C in the phase of viral liver cirrhosis and more.

 

Endocrinology (6%): treatment of type 2 diabetes.

In addition, the disorders to be treated with stem cells in the "other" category are:

Surgery: trophic ulcers of venous etiology, chronic and unhealed wounds (decubitus sores)

Proctology: chronic paraproctitis, fistulous form

Ophthalmology: corneal damage

Dentistry: gingival recession